Preclinical development of a replication-competent vesicular stomatitis virus-based Lassa virus vaccine candidate advanced into human clinical trials. [PDF]
Cooper CL +37 more
europepmc +1 more source
Robust polyfunctional CD8<sup>+</sup> and CD4<sup>+</sup> T cell responses in HLA-A*0201/DR1 transgenic mice following vaccination with modified vaccinia virus Ankara-based vaccines delivering Lassa virus glycoprotein or nucleoprotein. [PDF]
Tscherne A +10 more
europepmc +1 more source
Modelling Lassa virus dynamics in West African Mastomys natalensis and the impact of human activities. [PDF]
John RS, Fatoyinbo HO, Hayman DTS.
europepmc +1 more source
Identification of residues in Lassa virus glycoprotein 1 involved in receptor switch. [PDF]
Guo J +6 more
europepmc +1 more source
Spatio-temporal spread and evolution of Lassa virus in West Africa. [PDF]
Wang X +9 more
europepmc +1 more source
Reservoir displacement by an invasive rodent reduces Lassa virus zoonotic spillover risk. [PDF]
Eskew EA +14 more
europepmc +1 more source
An mRNA-LNP-based Lassa virus vaccine induces protective immunity in mice. [PDF]
Hashizume M, Takashima A, Iwasaki M.
europepmc +1 more source
Deciphering the enigma of Lassa virus transmission dynamics and strategies for effective epidemic control through awareness campaigns and rodenticides. [PDF]
Hamam H +6 more
europepmc +1 more source
Deep mutational scanning reveals functional constraints and antibody-escape potential of Lassa virus glycoprotein complex. [PDF]
Carr CR +8 more
europepmc +1 more source

